{"name":"Study Investigator-Sponsor","slug":"study-investigator-sponsor","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxQZHl4ZGRxQ0tnUDc0ZFpwdXRFSlNvU2k5cmVxcm9xbXhJb2VhNnVuaUJ4eXd1UVdfdm1QNnJIQ0c2SElucE9Hck1RZ2dZRi03RFl0eUZQOHNXQW9FTjR6Umg4WVhxbG1jaUJzXy04UHNfTzAzNnl3c1RiWFFVdUJOeTlGWFB3T1dORkVmS0t4ZlJJR1dZNENkRHhiU3BPRGtxMmIxaW5CVlI5eXRLNmtTYzVjekFoemJOTy05aDJCNU96YTI0WmtvaXpHUDJGWW5zdzVSQVdzWTFuSFphcmVJ?oc=5","date":"2026-04-08","type":"trial","source":"Investing.com","summary":"H.C. Wainwright reiterates Fennec Pharmaceuticals stock rating on expanded study - Investing.com","headline":"H.C. Wainwright reiterates Fennec Pharmaceuticals stock rating on expanded study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogJBVV95cUxQMW1qNklxVHVKdm42ekQ4NVFEXzNKYUVzSlFWNmo0T2VoZW4zSzl1UEJwSTJ4NWRXa3BzR1Q4MEluOEtMRF9iN1g1UFI0MHY2MGhDeldxYWFkZG9nX05GWHhic3ZRSnhiYTBFTmotZU9BbUFHVzU4ZzBrQks3Z1A2SEpBVldmWE5EUldGYkgxUDFFaVdteHJsa3FCeGNrU2dYdWpodVR5SXU2Uks3TWdrbzRSQ0d5bWNKZ2E2VWdsYnlQVFhGLUhnNS1KMDNGU2RXWUN6LTRrTVdoaUtya2p4dzc4TVYwWWN6ZGJXVHdrYkQwU21HaUM3MlZTUTFMUW11dmJiTHlxNGxBdXRnZXFUc0pleElBZGQ4Y08wVGh5bWdDUQ?oc=5","date":"2026-04-08","type":"trial","source":"Minichart","summary":"Fennec Pharmaceuticals Announces New Investigator-Sponsored Study of PEDMARK® for Preventing Cisplatin-Induced Hearing Loss in AYA and Adult Cancer Patients - Minichart","headline":"Fennec Pharmaceuticals Announces New Investigator-Sponsored Study of PEDMARK® for Preventing Cisplatin-Induced Hearing L","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOTFZIYl9SUWQ3RDUwekVtQV9QREJaTGdsMmRnSmg1aGNsLUg4UzJ3cEJ1WXRwZlRWWnNfVjZBR3U1Q3liX1U3QzVSaldQTDVfaHVuNlFKQndCdTFmVTYycFdUSlVRMndxQXlKLVNsTVN4MVBnSDRNNVF2RGpPMDBXYkxJRkR1bEc5NUxRZ2I5a09QYm1qbkFaY3VHM2pJQ0daSkRtOUdMSlBheGIwSGpadjhmM0JjUFFWekJHbDVqQQ?oc=5","date":"2026-04-07","type":"trial","source":"stocktitan.net","summary":"Can a hearing-loss drug help more adults on cisplatin? Arizona study starts - stocktitan.net","headline":"Can a hearing-loss drug help more adults on cisplatin? Arizona study starts","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"trial","source":"Pulse 2.0","summary":"Fennec Pharmaceuticals: University Of Arizona Cancer Center Investigator-Sponsored Study Advances PEDMARK In AYA And Adult Cancer Patients - Pulse 2.0","headline":"Fennec Pharmaceuticals: University Of Arizona Cancer Center Investigator-Sponsored Study Advances PEDMARK In AYA And Adu","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-04-07","type":"trial","source":"The Manila Times","summary":"Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center - The Manila Times","headline":"Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOOHpMbGZTQjNjVEl3OFdnbjBwWm50Z3ZxdzZ2bGExdGpoand4X3YzY0t3elQ1VTExNXVCU1VKTGJoUEV3U185a2ZiVmMwcXk0NG8tdzBLTXJHQnlsaDFIampnM0hLNVBHV2N2b3p0RjluRGloZ05IWFBySEphUFdiZVdFaTVCSFR3ZTVHMHh4T1FUa2tDeHVUNnlPcjlqNzhfOXotaXRnbHplVF9wZWs1c3pxVWVhSW5hYVBuc3VpU2pwTi1yLXdEUkZwREtyaTJoTlNPR0V6UXBpcks1c0M4VFBPVGpXYlE?oc=5","date":"2026-04-07","type":"trial","source":"marketscreener.com","summary":"Fennec Pharmaceuticals Inc. Announces Investigator-Sponsored Study of PEDMARK in AYA and Adult Patients With Solid Tumors Receiving Cisplatin - marketscreener.com","headline":"Fennec Pharmaceuticals Inc. Announces Investigator-Sponsored Study of PEDMARK in AYA and Adult Patients With Solid Tumor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxPeFhqNXhOa2M5cHlWckRuSlNURTdZWWpicEx3VUFnWG9MOWxXYjZ3MER2SmpoalFORC1UcUxXME03MUJsSFJxUlJ3U0dXTTN6U2VRRWlWWkxOV3YwM1FjN0Y4Zm5qakwwVWQ5ZjJXeklZN3B0aGhtMmE4MWxUY2VqNHdrZlJKVVFJTVNVYmpha0Q4ZXJwb3VGck9JanRyUV8zbm5IYVdtYWZhdVJaMk8zWjVkVV9Xdw?oc=5","date":"2026-04-07","type":"trial","source":"stocktitan.net","summary":"Fennec (FENC) backs new University of Arizona study on PEDMARK use in cisplatin-treated patients - stocktitan.net","headline":"Fennec (FENC) backs new University of Arizona study on PEDMARK use in cisplatin-treated patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxNZ3JmT2E3QkJncWpSb05MTlRLVXNGbVlzV1gxbTVJVXFtVWEzanV3Q2NvUDhsN0xpWnRBLUliX2ZhWlgxUVY1ZWJNeXduVkQ3LVE0LTFLQjNOVUlIdmlWR2lkRElqSHJ1c3VyLTZBSGd2WFJBa3BrbDc1c1pSaVNwNWhuOWhGUEdiUjhObWxZVEZXVWJPanN5bmFKLUtIOXlpbVRuUDBLei1XUQ?oc=5","date":"2025-09-15","type":"pipeline","source":"clinicalleader.com","summary":"How Brazil's New Law Is Redefining The Country's Clinical Research - clinicalleader.com","headline":"How Brazil's New Law Is Redefining The Country's Clinical Research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPdG5nWm5RRmdGSUVDWGhPRU5FWlVYMlgxVkJQWGhkSnBVN00xdXdqRDU0MHdodWJFY3ZCMWhBMjR0eWFhUWpjNFBHTXlZX3U3cERDTzFBQ0drWWdFWGlkQ0FpbGE5bUV4MVBKaG9LRWFHMjg5ZkdqVnJNZk1adURlRjB4dDNkQk40eHhpV2ZwZEkwVXlBaXVWQzVYMlVOekMzWkRWN3dlVmNQQ2NlMDJVYw?oc=5","date":"2025-06-03","type":"trial","source":"Pharmaceutical Executive","summary":"Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them - Pharmaceutical Executive","headline":"Five Critical Challenges in Investigator Site Selection and How Clinical Data Science Can Solve Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE1pci16U2ZJcXdxdzE1dXRXVUZ0X09vQVJ6SmhPUHZrSF9FbXhqVzJOU1JXVVhQSHo2OXVNZndNejMyTjRqSEE1MHFfZjg0cnh1YnZ4OVFQYTJhdUo5VndIQVlZdGZsSExLS0hVVXpTcXBlS3VXemVhQndYcjU?oc=5","date":"2025-05-05","type":"trial","source":"IQVIA","summary":"Today’s Investigator Databank and DQS: Welcoming the Next Generation of Consortium Members - IQVIA","headline":"Today’s Investigator Databank and DQS: Welcoming the Next Generation of Consortium Members","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPaE40TzU1SjhIemE2aG9aZlo1NnktWnJQUzFQU3FRZ29keGpPcjhaU2pWaGFjMDFXckE1WVgyLWlBV1JudFlRSVRFZ1VnZVoyQnJTZzVqUzJaRVcxaEhwOExaYU1OVlBOdnJHdk0xMUpIb05oNW1xOUgyazVPSzliVGJTVFNsQQ?oc=5","date":"2025-02-08","type":"pipeline","source":"Food and Drug Law Institute (FDLI)","summary":"Compliance Challenges for Clinical Research Sites - Food and Drug Law Institute (FDLI)","headline":"Compliance Challenges for Clinical Research Sites - Food and Drug Law Institute (FDLI)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxQdEZrdnRxRnBLYktLdjJnMlA5NnZ2QkFuZnFwUjBQSHFhNkRMaHc3WkhjVEhEb0xXc21hYXhUX0FObmpMS05oR29HaGZ0N1QtWEEwOUZOX3ZtekpXVGpmYUFadHZ6b0c4bXktTE1FZUdSU1RUVmY3dXYzbldwTnB1WU0zTVk1aU9hS2o0X0d3?oc=5","date":"2024-06-25","type":"trial","source":"Frontiers","summary":"Navigating the challenges of clinical trial professionals in the healthcare sector - Frontiers","headline":"Navigating the challenges of clinical trial professionals in the healthcare sector","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}